MOMI PODS for Postpartum Health
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
The MOMI PODS program shows promise in improving postpartum health by integrating outpatient care into pediatric structures, which increases access to healthcare and promotes better health outcomes for postpartum individuals, especially those who are publicly insured.
12345The MOMI PODS program is designed to improve postpartum care by integrating it into pediatric care structures, focusing on increasing access to healthcare for postpartum individuals. While the program aims to mitigate maternal health risks, the available research does not provide specific safety data or adverse event information related to the program itself.
14678MOMI PODS is unique because it integrates postpartum care into pediatric care structures, improving access to primary care and community resources for postpartum individuals, especially those who are publicly insured. This approach focuses on mitigating maternal health risks by providing a collaborative care model involving multiple healthcare disciplines, which is not typically seen in standard postpartum care.
19101112Eligibility Criteria
The MOMI Study is for new mothers and their infants, specifically those affected by conditions like metabolic syndrome or postpartum depression/anxiety. Participants are enrolled on the first day after giving birth and will be followed up with at 6 months and 1 year postpartum.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either MOMI PODS or Enhanced Usual Care (EUC) interventions, focusing on postpartum care and reducing disparities in postpartum risk.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with data collection at 6 months and 1 year postpartum.
Participant Groups
MOMI PODS is already approved in United States for the following indications:
- Postpartum care for mothers with cardiometabolic and/or mental health conditions